AWARE: An Observational Rheumatoid Arthritis Study

What we are studying

This is an observational study to collect information on infusion reactions on adults with rheumatoid arthritis who are taking Simponi Aria or Remicade.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosed with rheumatoid arthritis
  • Prescribed Simponi Aria or Remicade
  • Not taking/using any other investigational drugs or devices within 28 days of joining study

What is involved

  • Subject Questionnaires

Compensation

None

Contact Information

Study Coordinator
Judy Hooker
Email
[email protected]
Phone
(336)-716-0186
Principal Investigator
Francis C. Luk, M.D.

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.